RTP Mobile Logo

Saturday, June 2, 2018, Chicago, IL, 6:45 AM – 7:45 AM

Breakfast with the Investigators: Management of Melanoma

Event Details

Location:
Hilton Chicago
720 South Michigan Avenue
Chicago, IL 60605
Hotel Phone: (312) 922-4400

Time:
6:15 AM – 6:45 AM (Central Time) — Registration
6:45 AM – 7:45 AM (Central Time) — Educational Breakfast Meeting

Meeting Room:
Grand Ballroom (Level 2)

There is no registration fee for this event. However, preregistration is advised as seating is limited.  
 
Faculty:
Michael A Postow, MD
Assistant Attending Physician
Melanoma and Immunotherapeutics Service
Memorial Sloan Kettering Cancer Center
New York, New York

Professor Caroline Robert
Department Head, Dermatology Unit
Gustave-Roussy Institute
Paris, France


Jeffrey Weber, MD, PhD
Deputy Director
Laura and Isaac Perlmutter Cancer Center
Professor of Medicine
NYU Langone Medical Center
New York, New York

Moderator:
Neil Love, MD
Research To Practice
Miami, Florida

Not an official event of the 2018 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation.

This activity is supported by educational grants from Array BioPharma Inc, Bristol-Myers Squibb Company, Merck and Novartis.

Agenda

6:15 AM – 6:45 AM — Registration
6:45 AM – 7:45 AM — Educational Breakfast Meeting

This hour-long early-morning CME symposium will feature moderated panel discussions centered on the management of melanoma. Research To Practice president and medical oncologist Dr Neil Love will moderate the program. He will be joined by 3 renowned skin cancer investigators to discuss and debate emerging research related to novel agents and therapeutic strategies in an effort to identify current and future roles in clinical practice. The faculty members will also present actual patient cases from their practices, along with relevant radiographic and pathologic images, to further elucidate the optimal application of these agents to patient care. To cultivate a more conversational approach to the program, while a number of supporting data slides will be presented during the discussions, no didactic lectures will be included.

A detailed agenda will be made available in the coming weeks.

CE Information

Target Audience:
This program is intended for medical oncologists, hematology-oncology fellows and other allied healthcare professionals involved in the treatment of melanoma.

Learning Objectives and Goals:
At the conclusion of this activity, participants should be able to:

  • Identify patients after surgical removal of primary melanoma for whom adjuvant therapy should be considered, and counsel these individuals regarding the risks and potential benefits of existing and recently approved systemic approaches.
  • Appraise emerging clinical trial data evaluating the combination of BRAF and MEK inhibition for patients with resectable BRAF mutation-positive melanoma, and prepare for the possible availability of this approach in routine practice.
  • Consider age, performance status and other disease-related factors to guide the selection of first and later-line therapy for patients with metastatic BRAF wild-type melanoma.
  • Use available clinical trial evidence to safely and effectively incorporate targeted and immunotherapeutic approaches into the management of metastatic BRAF mutation-positive advanced melanoma.
  • Recall current investigational efforts to identify biomarkers of response to checkpoint inhibition, and consider how these may be applied in future clinical practice.
  • Recognize adverse events associated with immune checkpoint inhibitors, targeted therapies and other systemic treatments for melanoma, and offer supportive management strategies to minimize and/or manage side effects.
  • Appreciate the novel mechanism of action, endorsed clinical role and practical administration requirements of talimogene laherparepvec in order to support the safe and effective integration of this agent into current patient care.
  • Recall new data with investigational agents and strategies demonstrating promising activity in melanoma, and discuss ongoing trial opportunities with eligible patients.

CME Credit Form:
A CME credit form will be given to each participant at the conclusion of the activity.

Accreditation Statement:
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement:
Research To Practice designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy:
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.

Supporters:
This activity is supported by educational grants from Array BioPharma Inc, Bristol-Myers Squibb Company, Merck and Novartis.

Location

Hilton Chicago
720 South Michigan Avenue
Chicago, IL 60605
Hotel Phone: (312) 922-4400

Meeting Room:
Grand Ballroom (Level 2)

Directions:
The Hilton Chicago hotel is located just 5 minutes (2.5 miles) north of the McCormick Place convention center, where the ASCO Annual Meeting is taking place.

 

Registration

This program is intended for medical oncologists, hematology-oncology fellows and other allied healthcare professionals involved in the treatment of melanoma.

There is no registration fee for this event. However, preregistration is advised as seating is limited.

Registration for clinicians in practice

I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer.

Registration for clinicians in practice »
 
Registration for other/industry professionals*

Please note, a limited number of seats are currently available for nonclinicians on a first come, first served basis.

Registration for other/industry professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating, please check in at our onsite registration desk at least 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program, based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.